Suchergebnisse - "Arthritis"

PubPharm (19)

1

Triple conventional synthetic disease-modifying anti-rheumatic drugs for the management of rheumatoid arthritis : a review of cost-effectiveness

Erschienen: Ottawa, CADTH, March 26, 2019

CADTH rapid response report

Version: 1.0.

von Williams, D. | Butcher, R.

2

Pharmacoeconomic review report : indication : treatment of adult patients with active psoriatic arthritis who have responded inadequately to, or are intolerant to one or more disease-modifying antirheumatic drugs (DMARD)Ixekizumab (Taltz) (Eli Lilly Canada Inc.)

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, August 2018

CADTH common drug review

3

CADTH Canadian Drug Expert Committee recommendation : indication : adult patients with active psoriatic arthritis (PsA) who have responded inadequately to, or are intolerant to one or more disease-modifying antirheumatic drugs (DMARD)Ixekizumab (Taltz -- Eli Lilly Canada Inc.)

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, August 2018

CADTH common drug review

Version 1.0.

4

Rituximab maintenance therapy for the treatment and management of rheumatoid arthritis : a review of clinical effectiveness

Erschienen: Ottawa, CADTH, July 04, 2018

CADTH rapid response report: summary with critical appraisal

Version 1.0.

von Singh, K. | McCormack, S.

5

Drugs for the management of rheumatoid arthritis : clinical evaluation

Erschienen: Ottawa, CADTH, March 2018

CADTH health technology assessment - issue 146

von Wells, G.

6

Drug therapy for early rheumatoid arthritis : a systematic review update

Erschienen: Rockville, MD, Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, July 2018

Comparative effectiveness review - number 211

von Donahue, K.

7

Sarilumab (Kevzara)

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, May 2017

CADTH common drug review clinical review report

8

Pharmacoeconomic review report : Sarilumab (Kevzara)

Erschienen: Ottawa (ON), CADTH, May 2017

CADTH common drug review

9

Erschienen: Philadelphia, PA, Mosby/Elsevier, [2015]

Sixth edition

von Silman, A. | Smolen, J. | Hochberg, M. | +2

10

Drug therapy for psoriatic arthritis in adults : update of a 2007 report

Erschienen: Rockville, MD, Agency for Healthcare Research and Quality, [2012]

Comparative effectiveness review - no. 54

von Donahue, K.